HTD:FRA
Corcept Therapeutics Inc
€107.70
arrow_downward
-0.60%(-0.65) 1D
Oct 13, 8:00:55 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HTD...
Open
€107.70
High
€107.70
Low
€107.70
Mkt. cap
12.76B
Avg. vol.
7.00
Volume
0.00
52-wk high
€108.65
52-wk low
€27.49
No. of employees
730
Open
€107.70
High
€107.70
Low
€107.70
Mkt. cap
12.76B
Avg. vol.
7.00
Volume
0.00
52-wk high
€108.65
52-wk low
€27.49
No. of employees
730
News stories
From web sources and news partners
TradingView
·
5 hours ago
Are Options Traders Betting on a Big Move in Corcept Therapeutics Stock?
Profile
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD. Wikipedia
About Corcept Therapeutics Inc
CEO-
Employees730
FoundedMay 13, 1998
HeadquartersMenlo Park, California, United States
SectorPharmaceutical industry
Websitecorcept.com